1. A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5 mg/g viscosified gel formulation versus a modified formulation. (June 2020) Authors: Yendewa, George A.; Griffiss, J. McLeod; Jacobs, Michael R.; Fulton, Scott A.; O'Riordan, Mary Ann; Gray, Wesley A.; Proskin, Howard M.; Winkle, Peter; Salata, Robert A. Journal: Journal of global antimicrobial resistance Issue: Volume 21(2020) Page Start: 171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation. Issue 7 (July 2019) Authors: Waldman, Scott A.; Tenenbaum, Renata; Foehl, Henry C.; Winkle, Peter; Griffin, Patrick Journal: Clinical and translational gastroenterology Issue: Volume 10:Issue 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: A phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial. Issue 1 (8th July 2022) Authors: Viscusi, Eugene R.; de Leon‐Casasola, Oscar; Cebrecos, Jesús; Jacobs, Adam; Morte, Adelaida; Ortiz, Esther; Sust, Mariano; Vaqué, Anna; Gottlieb, Ira; Daniels, Stephen; Gimbel, Joseph S.; Muse, Derek; Winkle, Peter; Kuss, Michael E.; Videla, Sebastián; Gascón, Neus; Plata‐Salamán, Carlos Journal: Pain practice Issue: Volume 23:Issue 1(2023) Page Start: 8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial. Issue 10 (2nd October 2020) Authors: Turner, Mark; Papadimitriou, Athanasia; Winkle, Peter; Segall, Nathan; Levin, Michael; Doust, Matthew; Johnson, Casey; Lucksinger, Gregg; Fierro, Carlos; Pickrell, Paul; Raanan, Marsha; Tricou, Vianney; Borkowski, Astrid; Wallace, Derek Journal: Human vaccines & immunotherapeutics Issue: Volume 16:Issue 10(2020) Page Start: 2456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study. Issue 1 (8th February 2018) Authors: Fleischmann, Roy; Winkle, Peter; Miner, Jeffrey N; Yan, Xiaohong; Hicks, Liz; Valdez, Shakti; Hall, Jesse; Liu, Sha; Shen, Zancong; Gillen, Michael; Hernandez-Illas, Martha Journal: RMD open Issue: Volume 4:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study. Issue 1 (9th April 2018) Authors: Fleischmann, Roy; Winkle, Peter; Hall, Jesse; Valdez, Shakti; Liu, Sha; Yan, Xiaohong; Hicks, Liz; Lee, Caroline; Miner, Jeffrey N; Gillen, Michael; Hernandez-Illas, Martha Journal: RMD open Issue: Volume 4:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. (September 2021) Authors: Stöhr, Thomas; Colin, Pieter J.; Ossig, Joachim; Pesic, Marija; Borkett, Keith; Winkle, Peter; Struys, Michel M.R.F.; Schippers, Frank Journal: British journal of anaesthesia Issue: Volume 127:Number 3(2021) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetics of dalfampridine extended release 7.5‐mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open‐label study. (22nd October 2013) Authors: Samara, Emil; Winkle, Peter; Pardo, Patricia; Henney, Herbert R.; Way, Susan L.; Brown, Eppie; Lee, Angela; Blight, Andrew R. Journal: Journal of clinical pharmacology Issue: Volume 54:Number 1(2014:Jan.) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study. Issue 2 (8th December 2020) Authors: Singh, Ravi Shankar P.; Pradhan, Vivek; Roberts, Erika S.; Scaramozza, Matthew; Kieras, Elizabeth; Gale, Jeremy D.; Peeva, Elena; Vincent, Michael S.; Banerjee, Anindita; Fensome, Andrew; Dowty, Martin E.; Winkle, Peter; Tehlirian, Christopher Journal: Clinical and translational science Issue: Volume 14:Issue 2(2021) Page Start: 671 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗